Colonoscopy vs the Fecal Immunochemical Test : Which is Best?
Published by Elsevier Inc..
Although there is no debate around the effectiveness of colorectal cancer screening in reducing disease burden, there remains a question regarding the most effective and cost-effective screening modality. Current United States guidelines present a panel of options that include the 2 most commonly used modalities, colonoscopy and stool testing with the fecal immunochemical test (FIT). Large-scale comparative effectiveness trials comparing colonoscopy and FIT for colorectal cancer outcomes are underway, but results are not yet available. This review will separately state the "best case" for FIT and colonoscopy as the screening tool of first choice. In addition, the review will examine these modalities from a health economics perspective to provide the reader further context about the relative advantages of these commonly used tests.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:166 |
|---|---|
| Enthalten in: |
Gastroenterology - 166(2024), 5 vom: 22. Apr., Seite 758-771 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Robertson, Douglas J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Colonoscopy |
|---|
| Anmerkungen: |
Date Completed 23.04.2024 Date Revised 23.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1053/j.gastro.2023.12.027 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368317609 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368317609 | ||
| 003 | DE-627 | ||
| 005 | 20240424231948.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240212s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1053/j.gastro.2023.12.027 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1385.xml |
| 035 | |a (DE-627)NLM368317609 | ||
| 035 | |a (NLM)38342196 | ||
| 035 | |a (PII)S0016-5085(24)00164-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Robertson, Douglas J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Colonoscopy vs the Fecal Immunochemical Test |b Which is Best? |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.04.2024 | ||
| 500 | |a Date Revised 23.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Published by Elsevier Inc. | ||
| 520 | |a Although there is no debate around the effectiveness of colorectal cancer screening in reducing disease burden, there remains a question regarding the most effective and cost-effective screening modality. Current United States guidelines present a panel of options that include the 2 most commonly used modalities, colonoscopy and stool testing with the fecal immunochemical test (FIT). Large-scale comparative effectiveness trials comparing colonoscopy and FIT for colorectal cancer outcomes are underway, but results are not yet available. This review will separately state the "best case" for FIT and colonoscopy as the screening tool of first choice. In addition, the review will examine these modalities from a health economics perspective to provide the reader further context about the relative advantages of these commonly used tests | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Colonoscopy | |
| 650 | 4 | |a Colorectal Cancer Screening | |
| 650 | 4 | |a Fecal Immunochemical Test | |
| 650 | 4 | |a Health Economics | |
| 700 | 1 | |a Rex, Douglas K |e verfasserin |4 aut | |
| 700 | 1 | |a Ciani, Oriana |e verfasserin |4 aut | |
| 700 | 1 | |a Drummond, Michael F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Gastroenterology |d 1945 |g 166(2024), 5 vom: 22. Apr., Seite 758-771 |w (DE-627)NLM00001706X |x 1528-0012 |7 nnns |
| 773 | 1 | 8 | |g volume:166 |g year:2024 |g number:5 |g day:22 |g month:04 |g pages:758-771 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1053/j.gastro.2023.12.027 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 166 |j 2024 |e 5 |b 22 |c 04 |h 758-771 | ||